APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncolytic Virus

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Selected research

Industry Growth & Trends

Global Oncolytic Virus Industry Growth and Trends Forecast to 2032

29 December 202579 pages

Choose your research edition.

Industry ResearchOncolytic Virus Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncolytic Virus Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Oncolytic Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncolytic Virus Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncolytic Virus Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Oncolytic Virus market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncolytic Virus market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncolytic Virus market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncolytic Virus.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncolytic Virus market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncolytic Virus Market by Company

Amgen

Shanghai Sunway Biotech

Oncolytic Virus Segment by Type

Imlygic

Oncorine

Others

Oncolytic Virus Segment by Application

Melanoma

Other Cancers

Oncolytic Virus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncolytic Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Imlygic Table 2. Major Company of Oncorine Table 3. Major Company of Others Table 4. Global Oncolytic Virus Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 6. Global Oncolytic Virus Sales Market Share in Volume by Type (2021-2026) Table 7. Global Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 8. Global Oncolytic Virus Sales Market Share in Value by Type (2021-2026) Table 9. Global Oncolytic Virus Price by Type (2021-2026) & (US$/Unit) Table 10. Global Oncolytic Virus Sales by Type (2027-2032) & (K Units) Table 11. Global Oncolytic Virus Sales Market Share in Volume by Type (2027-2032) Table 12. Global Oncolytic Virus Sales by Type (2027-2032) & (US$ Million) Table 13. Global Oncolytic Virus Sales Market Share in Value by Type (2027-2032) Table 14. Global Oncolytic Virus Price by Type (2027-2032) & (US$/Unit) Table 15. North America Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 16. North America Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 18. Europe Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 22. Latin America Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Oncolytic Virus Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Oncolytic Virus Sales by Type (2021-2026) & (US$ Million) Table 25. Oncolytic Virus Industry Trends Table 26. Oncolytic Virus Industry Drivers Table 27. Oncolytic Virus Industry Opportunities and Challenges Table 28. Oncolytic Virus Industry Restraints Table 29. Global Oncolytic Virus Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Oncolytic Virus Revenue Market Share by Company (2021-2026) Table 31. Global Oncolytic Virus Sales by Company (2021-2026) & (K Units) Table 32. Global Oncolytic Virus Sales Share by Company (2021-2026) Table 33. Global Oncolytic Virus Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Oncolytic Virus Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Oncolytic Virus Major Company Production Sites and Headquarters Table 36. Global Oncolytic Virus Company, Product Type & Application Table 37. Global Oncolytic Virus Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Oncolytic Virus Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Oncolytic Virus Sales by Region (2021-2026) & (K Units) Table 42. Global Oncolytic Virus Sales Market Share in Volume by Region (2021-2026) Table 43. Global Oncolytic Virus Sales by Region (2021-2026) & (US$ Million) Table 44. Global Oncolytic Virus Sales Market Share in Value by Region (2021-2026) Table 45. Global Oncolytic Virus Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Oncolytic Virus Sales by Region (2027-2032) & (K Units) Table 47. Global Oncolytic Virus Sales Market Share in Volume by Region (2027-2032) Table 48. Global Oncolytic Virus Sales by Region (2027-2032) & (US$ Million) Table 49. Global Oncolytic Virus Sales Market Share in Value by Region (2027-2032) Table 50. Global Oncolytic Virus Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Oncolytic Virus Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 53. Global Oncolytic Virus Sales Market Share in Volume by Application (2021-2026) Table 54. Global Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 55. Global Oncolytic Virus Sales Market Share in Value by Application (2021-2026) Table 56. Global Oncolytic Virus Price by Application (2021-2026) & (US$/Unit) Table 57. Global Oncolytic Virus Sales by Application (2027-2032) & (K Units) Table 58. Global Oncolytic Virus Sales Market Share in Volume by Application (2027-2032) Table 59. Global Oncolytic Virus Sales by Application (2027-2032) & (US$ Million) Table 60. Global Oncolytic Virus Sales Market Share in Value by Application (2027-2032) Table 61. Global Oncolytic Virus Price by Application (2027-2032) & (US$/Unit) Table 62. North America Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 63. North America Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 65. Europe Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 69. Latin America Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Oncolytic Virus Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Oncolytic Virus Sales by Application (2021-2026) & (US$ Million) Table 72. Amgen Company Information Table 73. Amgen Business Overview Table 74. Amgen Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Amgen Oncolytic Virus Product Portfolio Table 76. Amgen Recent Development Table 77. Shanghai Sunway Biotech Company Information Table 78. Shanghai Sunway Biotech Business Overview Table 79. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shanghai Sunway Biotech Oncolytic Virus Product Portfolio Table 81. Shanghai Sunway Biotech Recent Development Table 82. North America Oncolytic Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 84. North America Oncolytic Virus Sales Market Share by Country (2021-2026) Table 85. North America Oncolytic Virus Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Oncolytic Virus Sales Market Share Forecast by Country (2027-2032) Table 87. North America Oncolytic Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Oncolytic Virus Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Oncolytic Virus Market Share by Country (2021-2026) Table 90. North America Oncolytic Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Oncolytic Virus Market Share Forecast by Country (2027-2032) Table 92. Europe Oncolytic Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 94. Europe Oncolytic Virus Sales Market Share by Country (2021-2026) Table 95. Europe Oncolytic Virus Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Oncolytic Virus Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Oncolytic Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Oncolytic Virus Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Oncolytic Virus Market Share by Country (2021-2026) Table 100. Europe Oncolytic Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Oncolytic Virus Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Oncolytic Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Oncolytic Virus Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Oncolytic Virus Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Oncolytic Virus Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Oncolytic Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Oncolytic Virus Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Oncolytic Virus Market Share by Country (2021-2026) Table 110. Asia-Pacific Oncolytic Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Oncolytic Virus Market Share Forecast by Country (2027-2032) Table 112. Latin America Oncolytic Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 114. Latin America Oncolytic Virus Sales Market Share by Country (2021-2026) Table 115. Latin America Oncolytic Virus Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Oncolytic Virus Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Oncolytic Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Oncolytic Virus Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Oncolytic Virus Market Share by Country (2021-2026) Table 120. Latin America Oncolytic Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Oncolytic Virus Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Oncolytic Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Oncolytic Virus Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Oncolytic Virus Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Oncolytic Virus Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Oncolytic Virus Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Oncolytic Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Oncolytic Virus Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Oncolytic Virus Market Share by Country (2021-2026) Table 130. Middle East and Africa Oncolytic Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Oncolytic Virus Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Oncolytic Virus Distributors List Table 135. Oncolytic Virus Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Oncolytic Virus Image Figure 2. Global Oncolytic Virus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncolytic Virus Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncolytic Virus Sales (2021-2032) & (K Units) Figure 5. Imlygic Image Figure 6. Global Imlygic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oncorine Image Figure 8. Global Oncorine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Oncolytic Virus Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Oncolytic Virus Market Share by Type 2025 VS 2032 Figure 13. North America Oncolytic Virus Sales Market Share in Volume by Type in 2025 Figure 14. North America Oncolytic Virus Sales Market Share in Value by Type in 2025 Figure 15. Europe Oncolytic Virus Sales Market Share in Volume by Type in 2025 Figure 16. Europe Oncolytic Virus Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Oncolytic Virus Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Oncolytic Virus Sales Market Share in Value by Type in 2025 Figure 19. Latin America Oncolytic Virus Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Oncolytic Virus Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Oncolytic Virus Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Oncolytic Virus Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Melanoma Image Figure 26. Global Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Cancers Image Figure 28. Global Other Cancers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Oncolytic Virus Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oncolytic Virus Market Share by Application 2025 VS 2032 Figure 31. North America Oncolytic Virus Sales Market Share in Volume by Application in 2025 Figure 32. North America Oncolytic Virus Sales Market Share in Value by Application in 2025 Figure 33. Europe Oncolytic Virus Sales Market Share in Volume by Application in 2025 Figure 34. Europe Oncolytic Virus Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Oncolytic Virus Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Oncolytic Virus Sales Market Share in Value by Application in 2025 Figure 37. Latin America Oncolytic Virus Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Oncolytic Virus Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Oncolytic Virus Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Oncolytic Virus Sales Market Share in Value by Application in 2025 Figure 41. North America Oncolytic Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Oncolytic Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Oncolytic Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oncolytic Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Oncolytic Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oncolytic Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oncolytic Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Oncolytic Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Oncolytic Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oncolytic Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Oncolytic Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Oncolytic Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oncolytic Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Oncolytic Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Oncolytic Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Oncolytic Virus Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Oncolytic Virus Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Imlygic
  • Oncorine
  • Others
Applications
  • Melanoma
  • Other Cancers
Companies covered
  • Amgen
  • Shanghai Sunway Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncolytic Virus Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncolytic Virus Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncolytic Virus Market by Type
  6. 1.3.1 Imlygic
  7. 1.3.2 Oncorine
  8. 1.3.3 Others
  9. 1.4 Global Oncolytic Virus Market Size by Type
  10. 1.4.1 Global Oncolytic Virus Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Oncolytic Virus Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Oncolytic Virus Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Oncolytic Virus Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Oncolytic Virus Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Oncolytic Virus Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Oncolytic Virus Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Oncolytic Virus Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncolytic Virus Industry Trends
  2. 2.2 Oncolytic Virus Industry Drivers
  3. 2.3 Oncolytic Virus Industry Opportunities and Challenges
  4. 2.4 Oncolytic Virus Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncolytic Virus Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncolytic Virus Sales (2021-2026)
  3. 3.3 Global Top Players by Oncolytic Virus Price (2021-2026)
  4. 3.4 Global Oncolytic Virus Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncolytic Virus Major Company Production Sites & Headquarters
  6. 3.6 Global Oncolytic Virus Company, Product Type & Application
  7. 3.7 Global Oncolytic Virus Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncolytic Virus Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncolytic Virus Tier 1, Tier 2, and Tier 3
4 Oncolytic Virus Regional Status and Outlook
  1. 4.1 Global Oncolytic Virus Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncolytic Virus Historic Market Size by Region
  3. 4.2.1 Global Oncolytic Virus Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncolytic Virus Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncolytic Virus Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncolytic Virus Forecasted Market Size by Region
  7. 4.3.1 Global Oncolytic Virus Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncolytic Virus Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncolytic Virus Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncolytic Virus by Application
  1. 5.1 Oncolytic Virus Market by Application
  2. 5.1.1 Melanoma
  3. 5.1.2 Other Cancers
  4. 5.2 Global Oncolytic Virus Market Size by Application
  5. 5.2.1 Global Oncolytic Virus Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oncolytic Virus Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oncolytic Virus Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oncolytic Virus Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oncolytic Virus Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oncolytic Virus Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oncolytic Virus Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oncolytic Virus Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Oncolytic Virus Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 Shanghai Sunway Biotech
  8. 6.2.1 Shanghai Sunway Biotech Company Information
  9. 6.2.2 Shanghai Sunway Biotech Business Overview
  10. 6.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
  12. 6.2.5 Shanghai Sunway Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Oncolytic Virus Sales by Country
  2. 7.1.1 North America Oncolytic Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncolytic Virus Sales by Country (2021-2026)
  4. 7.1.3 North America Oncolytic Virus Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncolytic Virus Market Size by Country
  6. 7.2.1 North America Oncolytic Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncolytic Virus Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncolytic Virus Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncolytic Virus Sales by Country
  2. 8.1.1 Europe Oncolytic Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncolytic Virus Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncolytic Virus Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncolytic Virus Market Size by Country
  6. 8.2.1 Europe Oncolytic Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncolytic Virus Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncolytic Virus Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncolytic Virus Sales by Country
  2. 9.1.1 Asia-Pacific Oncolytic Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncolytic Virus Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncolytic Virus Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncolytic Virus Market Size by Country
  6. 9.2.1 Asia-Pacific Oncolytic Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncolytic Virus Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncolytic Virus Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncolytic Virus Sales by Country
  2. 10.1.1 South America Oncolytic Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncolytic Virus Sales by Country (2021-2026)
  4. 10.1.3 South America Oncolytic Virus Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncolytic Virus Market Size by Country
  6. 10.2.1 South America Oncolytic Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncolytic Virus Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncolytic Virus Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncolytic Virus Sales by Country
  2. 11.1.1 Middle East and Africa Oncolytic Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncolytic Virus Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncolytic Virus Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncolytic Virus Market Size by Country
  6. 11.2.1 Middle East and Africa Oncolytic Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncolytic Virus Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncolytic Virus Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncolytic Virus Value Chain Analysis
  2. 12.1.1 Oncolytic Virus Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncolytic Virus Production Mode & Process
  7. 12.2 Oncolytic Virus Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncolytic Virus Distributors
  10. 12.2.3 Oncolytic Virus Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst